eChapters

Introduction
Haemoprotozoan diseases are highly prevalent in tropical and sub-tropical countries owing to the ubiquitous distribution of ticks and blood-sucking flies which are natural vectors for the pathogens. In India, theileriosis, babesiosis and trypanosomosis are major haemoprotozoan diseases and cause substantial economic losses to the livestock industry. Though vaccination of the susceptible stock by attenuated schizont vaccine is available for the control of tropical theileriosis in cattle, chemotherapy is the mainstay for the control of haemoprotozoan diseases. However, the limited available antihaemoprotozoan drugs is being depleted by a combination of two factors viz. emergence of drug resistance and the failure to replace old drugs (de Koning, 2017). Drug resistance against parasites is one of the emerging problems affecting veterinary health sector. Since last few decades, development of drug resistance in haemoprotozoan parasites to several drugs has been reported (Tuvshintulga et al., 2019; Ali et al., 2022). Though, understanding of drug resistance in parasitic protozoa is progressing steadily but possibly not as rapidly as parasites are becoming resistant to drugs. The genetic changes in the target sites, the reduced uptake and increased efflux of drugs, and metabolic regulations are the possible mechanism for the cause of drug resistance (Fairlamb et al., 2016). Anti-protozoan drug resistance has been reported in many economically important protozoa to isometamedium, diminazene aceturate, quinapyramine, suramin, melarsomine dihydrochloride, buparvaquone. The resistance initially evolves at genetic level of parasite with genetic traits that allow them to survive exposure to a drug, which is transferred to the subsequent generation thereby potentially increasing the percentage of resistant parasite that can survive subsequent exposure to the chemical. The emergence of drugresistant parasites has serious implications for treating clinical cases, leading to increased morbidity and mortality among the animals and control of the diseases.

Introduction
Antimicrobial resistance (AMR) is a global concern that poses a significant threat to contemporary healthcare systems, potentially hindering the management and treatment of various diseases. Microorganisms can act as reservoirs for AMR across various ecological niches; thus, a “one health” proposal is essential for coordinating a multisectoral strategy aimed at investigating and tackling this alarming issue. This method seems to be an effective strategy for addressing and alleviating the challenges posed by AMR; however, it demands the collaborative efforts and assets that are consistently and efficiently executed by health practitioners. Horses have been pivotal in human history; they have served in wars, provided transportation, and even aided in mining operations. In contemporary society, horses are significant as sport animals and in therapeutic settings involving animals. Given these close interactions between humans and equines, it becomes essential to effectively identify infectious diseases and antimicrobial resistance (AMR) impacting both species, particularly in instances of highly contagious diseases. Resistant bacteria represent a significant threat to the health of both equines and humans. Horses may obtain resistant bacteria through several avenues, such as interaction with other animals, exposure to contaminated materials, or to antibiotic uses. The responsible utilization of antibiotics and the implementation of antimicrobial stewardship programs are essential in reducing the transmission of antimicrobial resistance (AMR) within equine populations. A variety of zoonotic pathogens that exhibit resistance to antibiotics has been identified in equines. This includes Extended-Spectrum Beta-Lactamases (ESBL) which produces E. coli, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Multidrug-Resistant (MDR) Salmonella. Horses can develop AMR through various channels like:

Introduction
Antibiotic-resistant E. coli develops as a result of the heavy use of antibiotics in the production of food animals, which is then found in the meat from those animals. There have been reports of a number of antimicrobial resistant E. coli infections linked to the ingestion of tainted milk and chevon. As a result, the existence of antibiotic resistant E. coli is a significant and expanding global public health risk. Escherichia coli of animal origin has also been seen to colonise humans, and because it is resistant to many conventional antibiotics, it can cause serious illnesses for which there are few effective treatment choices. Due to its ubiquitous presence in the environment, E. coli has traditionally been recognised as the main vehicle for the transmission of various antibiotic resistance genes and vectors.Extended-spectrum beta-lactamases (ESBLs), which can make the bacteria resistant to some frequently used antimicrobial treatments, are tiny proteins (enzymes) that some strains of E. coli have been shown to manufacture under favourable conditions. A major issue around the world is the emergence of different E. coli strains that produce ESBL in foods that come from animals that are raised for food. The ESBL enzymes TEM, SHV, and CTX-M from Group A have been widely reported to be generated by E. coli and have been shown to hydrolyze ampicillin, carbenicillin, oxacillin, and an extended spectrum of cephalosporins, including ceftazidime and cefotaxime.
Extended beta spectrum lactamase producing E. coli
The occurrence of antimicrobial resistance and the presence of corresponding resistance genes in the environment is an ancient phenomenon. This is largely due to the fact that many of today’s antimicrobial agents are derived from natural precursors produced by soil bacteria such as Streptomyces. These natural compounds likely evolved to mediate microbial competition for

Introduction
Aquaculture is one of the sunrise sectors contributing a significant quantity to the global supply of fish for human consumption. Fish is a superior source of highquality animal protein and highly digestible energy. Disease problems in farmed fishes are one of the main barriers, resulting in significant financial losses up to a tune of US$2.48 B, 14.95% of the annual aquaculture production value in Indian aquaculture. In the aquatic environment, bacteria are quite prevalent and the majority of bacterial pathogens are found in the water’s natural flora. They only spread illness when poor husbandry practices, inadequate nutrition, and unfavourable environmental circumstances contribute to fish stress. Pathogenic bacteria, including Aeromonas spp, Escherichia coli, Staphylococcus spp, Salmonella spp., Shigella spp., Yersinia enterocolitica, Clostridium botulinum, Plesiomonas shigelloides, and Listeria monocytogenes, can be either naturally present in fish or introduced to them during handling, processing, and storage. Antimicrobial resistance (AMR) in Indian aquaculture presents a multifaceted and growing challenge at the intersection of public health, environmental sustainability, and food security. As aquaculture expands to meet rising global demands for protein, the sector has increasingly relied on antimicrobials to prevent and treat bacterial infections. However, due to some indiscriminate and unregulated use of these agents as well as the householdsewage, hospital effluents, contamination from agricultural wastes andinadequately treated urban waters that enter the aquaculture through drains and rivers,creates strong selective pressure and accelerate the development and dissemination of resistant pathogens in aquatic environments posing a serious threat not only to farmed fish but also to human health through environmental contamination and the broader food chain. Resistant bacteria and resistance genes can spread through water systems, biofilms, and aquaculture products, creating reservoirs that contribute to the broader One Health AMR crisis. Food borne pathogens (Aeromonas spp., Vibrio spp., and Streptococcus spp.) from aquatic animals were found resistant to antimicrobial agents that are relevant for therapeutic usage in human clinical settings. E. coliwas found to be resistant as a sign of possible human and terrestrial animal effects. Distinguishing resistance that has been selected in different sectors is extremely difficult and caution is needed while trying to attribute the source of antibiotic resistance in bacteria in the aquatic environment. Understanding the drivers, mechanisms, and impacts of AMR in aquaculture is essential for developing effective mitigation strategies and sustainable management practices that safeguard both aquatic and human health.

Introduction
Antimicrobial resistance (AMR) is regarded as a silent pandemic that is responsible for causing the majorityof deaths every year and has become a major healthcare challenge and a significant public health issue. It has been reported that AMR alone has caused more fatalities than road accidents and cancer. It is among the top ten global health threats and has been recognized as a part of the multisector One Health approach. It has been predicted that by the year 2050, the burden of AMR will decrease the gross domestic product (GDP) by 2 to 3.5%, causing a loss of USD100 trillion to the world, with the annual death rate reaching 10 million. India faces one of the world’s highest antimicrobial resistance (AMR) rates, driven by high antibiotic consumption in humans, widespread non-prescription use, and unregulated application in livestock, aquaculture, and agriculture. Surveillance data show alarming resistance in major pathogens E. coli and Klebsiella,which now exhibit very low susceptibility to key antibiotics such as cefotaxime, ciprofloxacin, and carbapenems. Factors exacerbating the burden include inadequate infection prevention, limited laboratory capacity, poor enforcement of regulations, environmental contamination from pharmaceutical and hospital waste, and low public awareness. The combined impact threatens public health, food safety, and the economy. In general terms, AMR is defined as the ability of the microorganisms to withstand the action of an antimicrobial agent,i.e. Antibacterial agents, antifungal agents, potentially toxic metals, and disinfectants. AMR is known to be a natural process that occurs over time due to genetic changes in the pathogens under selective pressure, where a pathogen undergoes mutations and is often linked to indiscriminate use of antimicrobial agents.
Indefinite and improper use of antimicrobial agentshas been a major factor in the emergence of AMR. AMR affects both animals and humans alike, and resistant pathogens pose a challenge in treating infections. One of the crucial factors responsible for AMR is theenvironment, which is regarded as both a vehicle for spreading AMR microbes as well is a culprit of AMR pollutants, which severely impact the ecosystems. AMR is a multifaceted problem and to control it effectively, meticulous measures have been implemented for monitoring and surveillance of AMR in clinical settings, in both human and veterinary fields. However, the environmental surveillance dealing with the environmental AMR has yet to be established. The implementation of comprehensive monitoring of AMR in environment will vastly improve our understanding of the various dissemination routes and propagation of the resistant microbes in environment and their role in spreading AMR. In this chapter, we will discuss the environmental spread of AMR, drivers of AMR in the environment, factors influencing AMR, challenges faced, measures to tackle AMR, and future trends in curbing the burden of AMR.

Introduction
Infection prevention and control refers to prevention and control of infections and their transmission in healthcare settings. Healthcare Associated Infections (HAI) are one of the most common adverse events in delivery of care and a major public health problem with an impact on morbidity, mortality and quality of life. Up to 7% of patients in developed and 10% in developing countries acquire at least one HAI. These infections also present a significant economic burden for the health system.1It is evident that HAIs result in prolonged hospital stays, long-term disability, increased resistance of microorganisms to antimicrobials, additional cost on health systems, high cost for patients and their family, and preventable deaths.
The core components of IPC2
• IPC programme at the national and health facility level
• National and facility level evidence-based guidelines on IPC
• Education and training
• HAI surveillance
• Multimodal strategies
• Monitoring and audit of IPC practices and feedback
• Workload, staffing and bed occupancy
• Built environment, materials and equipment for IPC
HAI Burden
HAI are one of the most common adverse events in healthcare delivery and a major public health problem with an impact on morbidity, mortality and

Antimicrobial resistance (AMR) is a mounting global health emergency that threatens the effectiveness of modern medicine and veterinary care. In India, the challenge is compounded by high antibiotic consumption, unregulated access to antimicrobials, and widespread use in agriculture and animal husbandry. The World Health Organization has identified the Eskape pathogens— Enterococcus faecium, Staphylococcus aureus, Klebsiellapneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp, as priority organisms due to their ability to “escape” the effects of antibiotics and cause life-threatening infections. Simultaneously, zoonotic transmission of resistant bacteria from animals to humans is emerging as a critical concern, particularly in regions with close human-animal interfaces like Jammu & Kashmir. The importance of Eskape pathogens to the establishment and promotion of antimicrobial resistance in hospitalized patients was first recognized in a 2008 by Rice. The morbidity and mortality associated with Gram-negative Eskape pathogens is particularly concerning, as new antimicrobial agentsthose with activity against multidrug-resistant and pan-resistant Gram-negative strainshave not emerged as quickly as needed. Consequently, nosocomial infections continue to pose a serious threat to patient health, especially among critically ill inpatients and those undergoing invasive procedures or requiring the placement of medical devices. Eskape pathogens are well known for their intricate resistance mechanisms, often leaving clinicians with limited therapeutic options. Due to their significant role in driving antimicrobial resistance within hospital settings, consistent and systematic monitoring of their resistance profiles is crucial for guiding effective infection control and therapeutic strategies.This also serves as a critical indicator of regional resistance trends among hospitalized populations. In animal sector, the wastewater of livestock slaughterhouses, animal products (raw or processed) have been considered a source of multidrugresistant bacteria with clinical implications as well as their dissemination into the environment and entry into human food chain.Bacteria from the livestock can act as opportunistic pathogens and carry resistance genes that are important for both veterinary and human health. Since many antibiotics are used in both human and animal health fields, the resistant bacteria enter the environmentespecially through wastewater treatment plants affected by slaughterhouse wasteposing risks to public health. Among the various sources, the water used during poultry slaughtering often contains multidrug-resistant bacteria and can expose slaughterhouse workers to infection. To reduce these risks, it’s important to develop strategies that limit bacterial release into the water systems and prevent their spread to people and the environment. The development of AMR has been attributed to several factors comprising of microbial mutations rendering the antibiotics ineffective, human interference such as over use and over-prescription of antimicrobials, agricultural and commercial application of antimicrobials in the animal sector, and human behavioural factors (Vijayalaxmi et al., 2021). An expected annual rise of antimicrobial resistance (AMR) by 5–10 % annually has been predicted by the Indian Council of Medical Research (ICMR) Annual Report 2021 due to wide spread abusive use of broad-spectrum antibiotics (ICMR Annual Report 2021). Twelve families of priority drug-resistant bacteria (critical, high and medium) posing great threat to human health in terms of resistance to selected antimicrobials have been identified in priority pathogen list (PPL) of Global Action Plan, World Health Organisation (WHO) to stimulate the research towards the development of new antimicrobials against a particular drug-resistance (WHO,2017). From the Indian perspective, AMR is a grave concern as the Indian population is the highest consumer of antibiotics in the world (10.7 units per person). The poor public health systems, hospital infections, high rate of infectious diseases, easy availability of inexpensive

Introduction
The emergence and spread of antimicrobial resistance has changed the landscape of infectious disease treatment, creating an urgent need for new diagnostic and therapeutic approaches4’7. Traditional phenotypic antimicrobial susceptibility testing, while remaining the gold standard, requires 24-72 hours for results and provides limited insights into resistance mechanisms. Limited turnaround time is often a constraint that requires empirical use of antibiotics, potentially driving the propagation of other resistance emergence as well as suboptimal patient outcomes. Thanks to mass spectrometry, clinical microbiology has greatly benefitted through the rapid detection of pathogens. However, the application is far broader than species identification. The integration of multiple omics fields like proteomics, metabolomics, genomics, and transcriptomics through mass spectrometry provides unprecedented means to unravel, predict, and combat antimicrobial resistance (AMR) on a molecular level. The use of a multiomics approach is demonstrated to show that AMR is a complex phenotype that arises from the intersection between genetic mutations, variations in gene expression, metabolic differences, and changes in protein structures that all act in unison to affect bacterial survival in the presence of antibiotics. The conversion of raw mass spectrometry outputs into clinical insights amenable to decision-making is dependent upon bioinformatics. Through the use of sophisticated computational methodologies, such as machine learning and network analysis, bioinformatics provides the means to incorporate heterogeneous omics datasets. Through this approach, resistance-related biomarkers can be identified, predictions for therapeutic efficacy can be made, and new targets for intervention can be identified. The intersection between high-resolution mass spectrometry, broad-based omic profiling, and strictbioinformatics provides a powerful platform for addressing the intractable challenge of antimicrobial resistance.

Introduction
Antimicrobial resistance (AMR) poses an escalating threat to global health, eroding the efficacy of antibiotics and complicating the management of bacterial infections. The proliferation of resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum betalactamase (ESBL)-producing Enterobacteriaceae, and multidrug-resistant Mycobacterium tuberculosis, has driven significant increases in morbidity, mortality, and healthcare costs. The ability to detect AMR accurately and promptly is paramount for guiding clinicians in selecting effective therapies, implementing targeted infection control measures, and informing public health strategies to curb the spread of resistant organisms. Conventional methods, rooted in phenotypic assessments, have served as the cornerstone of AMR detection in clinical microbiology laboratories for decades. These techniques evaluate bacterial growth under controlled exposure to antibiotics, offering direct evidence of resistance or susceptibility that molecular approaches, which focus on genetic markers, may miss due to silent mutations, complex regulatory mechanisms, or novel resistance pathways. This chapter provides an exhaustive examination of conventional AMR detection methods, encompassing disk diffusion, broth and agar dilution, gradient diffusion, and automated susceptibility testing systems. These approaches, refined through decades of clinical and research application, remain indispensable for their reliability, cost-effectiveness, and adaptability across diverse settings, from well-resourced tertiary hospitals to laboratories in low-income regions. By exploring their principles, procedures, applications, and limitations, we aim to underscore their enduring significance amidst the rise of rapid molecular diagnostics. The discussion also addresses specialized tests for detecting specific resistance mechanisms, such as beta-lactamase production, inducible clindamycin resistance, and carbapenem’s activity, which are critical for tailoring antimicrobial therapy. Through a critical lens, this chapter evaluates the strengths and challenges of these methods, offering insights into their role in addressing the global AMR crisis, their integration with emerging technologies, and their continued relevance in both routine diagnostics and epidemiological surveillance. The value of conventional methods lies in their ability to translate laboratory findings into actionable clinical decisions. Unlike genotypic methods, which detect resistance genes but may not predict phenotypic behaviour, these techniques assess how bacteria respond to antibiotics under conditions mimicking in vivo environments, aligning closely with therapeutic outcomes. As resistance patterns grow increasingly complex, driven by mechanisms like carbapenem’s and efflux pumps, conventional methods provide a practical foundation for diagnostics, particularly in resource-limited settings where advanced molecular tools are often inaccessible. Their role in global AMR surveillance, such as through the World Health Organization’s Global Antimicrobial Resistance Surveillance System (GLASS), further underscores their importance in tracking resistance trends and informing policy.

Introduction
India has been making steady progress in the livestock sector with significant rise of meat, egg and milk production and a sustained annual growth rate of more than 5%. This growth trajectory is anticipated to accelerate further due to rising middle-class incomes combined with high income elasticity of demand for livestock products. However, despite having huge livestock resource, protein deficiency in rural India remains widespread. Recent data shows that two third of the Indian households are deficient in protein intake1. Looking at the growth potential in the sector, Govt. of India has put special focus on this sector and have undertaken many initiatives to boost animal health productivity and to increase farmer’s income. However, a major limiting factor in profitable livestock production in India is the high prevalence of infectious diseases. These livestock diseases cause great socioeconomic impact and are often exacerbated by inadequate biosecurity measures both in intensive and open production systems. Consequently, the use of antimicrobials for disease treatment has become an essential aspect of livestock management. Antibiotics usage in Animal Healthcare Antibiotics are an essential part of therapeutic management of infectious diseases in both farm and companion animals, ensuring better animal health and life; thereby also assures healthy food from the animal sources. In India a wide range of antibiotics are available in the veterinary practice viz. Penicillin, Semi-synthetic penicillin like Ampicillin, Amoxycillin, Aminoglycosides like Streptomycin, Gentamicin, Neomycin; Tetracycline, Kanamycin, Erythromycin; Fluoroquinolones like Enrofloxacin, Norfloxacin, Ciprofloxacin,

Introduction
Antimicrobial resistance (AMR) represents one of the most significant public health challenges of modern times. The discovery of antibiotics in the early 20th century revolutionized medicine, transforming once-fatal infections into manageable conditions and enabling life-saving procedures such as organ transplantation, chemotherapy, and joint replacement surgery. However, the overuse and misuse of antibiotics in human medicine, veterinary practice, and agriculture have accelerated the development of resistant microorganisms. Today, infections caused by resistant pathogens claim millions of lives worldwide each year, with the World Health Organization warning of a postantibiotic era in which minor injuries or routine surgeries could again become life-threatening. Although AMR is often framed within the context of hospital-acquired infections and clinical treatment failure, its implications extend much further. In particular, AMR has significant consequences for physical and health fitness. For athletes, soldiers, patients in rehabilitation, and physically active individuals, resistant infections can disrupt performance, delay recovery, and compromise long-term health. The increasing prevalence of resistant organisms in community environments—including gyms, swimming pools, and sports facilities—further raises concern. This chapter situates AMR at the intersection of clinical medicine, sports science, and community health. It explores how resistant pathogens affect physically active populations, complicate rehabilitation processes, and influence outcomes in both competitive and recreational Fitnes. It also highlights the global and national responses to AMR, preventive strategies relevant to Fitnes and rehabilitation, and the role of healthcare professionals

Introduction 
The discovery of antibiotics—one of the greatest medical breakthroughs of the 20th century—began when Sir Alexander Fleming noticed that the fungus Penicillium notatum inhibited the growth of Staphylococcus spp. This finding sparked a search for similar properties in other fungi and bacteria. From 1940 to 1960, known as the ‘Golden Era of Antibiotic Discovery’, most modern antibiotics such as streptomycin, tetracycline, rifampicin, and nalidixic acid were identified through natural product screening (Clardy et al., 2006; Lewis, 2013). However, the declaration that “it is time to close the book on infectious diseases and declare the war against pestilence won” proved to be premature (Davies & Davies, 2010). It was not a final victory but a fragile truce. In the ongoing war between humans and microbes—nature’s own creations—our successes are brief, and the microbial battleground keeps shifting. Bacteria’s genetic adaptability, coupled with human complacency, led to antimicrobial resistance (AMR), where microbes gradually evolved resistance to almost all known antibiotics (Ventola, 2015). Resistance appeared soon after antibiotics entered clinical use, but the emergence of methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Mycobacterium tuberculosis, and extended-spectrum ß-lactamase (ESBL)-producing bacteria marked major setbacks (Prestinaci et al., 2015; WHO, 2023). AMR gained global attention with the rise of pan-drug-resistant strains—resistant to all antibiotic classes—seen in Klebsiella (India), Acinetobacter, and Pseudomonas (China, Italy, Greece), and extensively drug-resistant tuberculosis (XDR-TB). The infamous case of

Introduction
The advent of antibiotics, beginning with penicillin in 1941, transformed medicine by rendering bacterial infections treatable [1]. However, antimicrobial resistance (AMR) has emerged as a profound threat, enabling bacteria to survive in the presence of drugs designed to inhibit or kill them and these are rooted in ancient microbial ecosystems evidenced by resistome genes in 30,000-year-old permafrost [2]. AMR has been exacerbated by human practices: approximately 50% of antibiotic prescriptions are inappropriate, 70% of global antibiotics fuel agriculture, and environmental pollution creates resistance hotspots [1]. By 2025, AMR directly causes 1.3 million deaths annually, with economic losses projected at $100 trillion by 2050 [1]. Priority pathogens, including carbapenem-resistant Enterobacteriaceae (CRE), methicillin-resistant Staphylococcus aureus (MRSA), and colistin-resistant strains via mcr-1, challenge last-resort therapies, particularly in low-resource settings [3]. This chapter delivers a technically extraordinary exploration of AMR, structured into genetic, biochemical, and evolutionary mechanisms, each elaborated with molecular precision and step-by-step clarity for learners. Genetic alterations provide the DNA-level foundation, biochemical pathways execute molecular defenses, and evolutionary forces drive adaptation and dissemination. It ensures scientific rigor and broad appeal for students, researchers, clinicians, and policymakers.
Historical Context and Global Burden
AMR emerged shortly after antibiotics’ introduction, with penicillin-resistant S. aureus identified by 1942 due to ß-lactamase production [1]. The 1960s

Introduction 
Antimicrobial resistance (AMR) is one of the most significant global health challenges of the 21st century. Defined as the ability of microorganisms— including bacteria, viruses, fungi, and parasites—to resist the effects of antimicrobial drugs, AMR undermines the progress of modern medicine. Antimicrobials—including antibiotics, antivirals, antifungals, and antiparasitics—are the cornerstone of modern medicine. Their discovery transformed the treatment of infectious diseases and enabled surgical advances, chemotherapy, and organ transplantation. However, Alexander Fleming, the discoverer of penicillin, warned that misuse could render these drugs ineffective. Antibiotics, since their discovery in the 20th century, revolutionized healthcare, saving millions of lives and enabling complex medical procedures. Yet, the misuse and overuse of antimicrobials in human health, veterinary practices, and agriculture have rapidly accelerated the emergence of resistant organisms. Today, this warning has materialized as a global crisis. Antimicrobial resistance (AMR) is now considered one of the top ten public health threats by the World Health Organization (WHO). It is not only a biomedical issue but also a socio-economic and developmental challenge. This chapter aims to provide an in-depth overview of AMR, focusing on definitions, history, mechanisms, causes, global status, impacts, and the urgency of mitigation efforts. It also explores national and global responses and future directions to curb the spread of AMR. AMR is estimated to cause 700,000 deaths annually worldwide, with projections of 10 million deaths annually by 2050 if urgent interventions are not implemented. In addition to health impacts, AMR poses grave threats to food security, sustainable agriculture, economic stability, and global development. This chapter provides a comprehensive overview of AMR, including definitions and conceptual frameworks, historical background, mechanisms of

India, a predominantly agrarian nation, relies heavily on agriculture for livelihoods. Over the decades, agricultural policies have focused on increasing the supply and accessibility of staple grains. This strategy has successfully reduced hunger and transformed the country’s food system (Pingali et al., 2019). At the forefront of this transformation stands Punjab that played a pivotal role in moving India from a food scarcity to self-sufficiency. Punjab’s agricultural success is globally recognized, driven by the rapid technology adoption, enabled through synergy of infrastructure, incentives and most critically, information (Singh & Kohli, 1997). Among these drivers, dissemination through agricultural extension proved instrumental in ensuring that innovations such as high-yielding variety (HYV) seeds, irrigation facilities and market incentives reached farmers effectively. While various factors contributed to Punjab’s growth, but agricultural extension remains a cornerstone, translating research breakthroughs into fieldlevel impact. Punjab Agricultural University (PAU) has been a key catalyst in this journey. while serving as a premier institution in agricultural research, education, and extension. PAU’s extension system has evolved in response to shifting agricultural needs, environmental challenges, and technological advancements. Beginning in 1960s, PAU led the Green Revolution by introducing HYVs and modern agricultural inputs through a dedicated, farmer-focused extension network (Gulati et al., 2018). In its early decades, PAU’s extension services emphasized increasing productivity through mechanization and the use of fertilizers and pesticides. Initiatives such as Kisan Melas (Farmers’ Fairs) and Kisan Clubs’ facilitated knowledge transfer to rural communities, fostering large-scale adoption of new technologies. However, by the late 1980s, concerns such as soil degradation and pest resistance prompted a strategic pivot. The PAU approach shifted from purely productivity-focused methods to more sustainable and diversified practices such as Integrated Nutrient Management (INM), integrated weed management (IWM) Integrated Pest Management (IPM), water conservation, etc. Today, PAU continues to modernize its extension practices through participatory, farmer-centric approaches. The current emphasis lies in promoting innovation, entrepreneurship, adaptability and sustainability through a blend of traditional outreach and modern ICT tools. Notable innovative approaches include e-extension services via mobile apps and online portals, real-time advisory systems through SMS and digital platforms, hybrid training modules

Introduction
In Indian agriculture and its sub sectors contribute for about 18.4 per cent of the Gross Domestic Product (GDP). Globally, our country is being rated as on of the rapid growing major economies and rated as fifth largest economy by nominal GDP and in Purchasing Power Parity (PPP) its 3rd largest in the world. The horticultural crops have a special place in India’s economy because they raise rural residents’ incomes. India’s horticulture production has surpassed food grain production and reached 320.11 million MT which is a huge accomplishment. In Andhra Pradesh the horticulture crops are spread across 17.84 lakh ha with 312.34 lakh MT yield. Andhra Pradesh is first in terms of fruit and spice producing area, and second in terms of micro irrigation area coverage. The horticulture industry makes for around 16.07 percent of the state Gross Value Addition. In India, Andhra Pradesh ranks first in the production of tomatoes, oil palm, papaya, cocoa, chillies, and cocoa, and second in cashew, mango, and sweet orange. Horticulture is increasingly being recognized as a sunrise industry because of its potential to boost farm income, provide a stable source of livelihood, and generate foreign exchange through exports. India’s distinctive agro-climatic conditions, coupled with its vast diversity of crops and genetic resources, enable the country to produce a wide range of horticultural crops year-round. The Government of Andhra Pradesh crafted Andhra Pradesh Horticultural University in Venkataramannagudem, West Godavari district in 2007, subsequently renamed as Dr. YSR Horticultural University in 2011. This was done in recognition of the importance of horticulture, its development potential in the state, and its contribution to the GDP. The university’s mission is to develop human resources by teaching, doing research that is focused on local needs and conditions, and disseminating tested technologies through Extension operations. The university is working on technology transfer (extension activities) through Krishi Vigyan Kendras (KVKs), Horticultural Research Stations (HRSs), Colleges of Horticulture, and Horticultural Polytechnics, as well as through Rythu Bharosa Kendrams (RBKs), District Resource Centers (DRCs), and the Department of Horticulture, Government of Andhra Pradesh. To “Reach the

Introduction
Karnataka Veterinary, Animal and Fisheries Sciences University (KVAFSU),
Bidar started in the year 2005 exclusively for the development of education and learning; conduct of research and extension education and transfer of rural oriented technologies in the areas of Veterinary, Animal, Dairy and Fisheries Sciences in Karnataka. The logo of the University is inscribed with the slogan “Farmers Friendly and Rural Oriented”, which emphasizes the importance given to betterment of farming community. The mission of Karnataka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Bidar, is to strive hard and provide leadership in teaching, research and extension education services related to Veterinary and Animal sciences, Dairy sciences, Fisheries and other allied sciences. The University endeavor is to keep pace with new frontiers of science and contemporary developments to be socially and technically relevant. In this context, KVAFSU is strongly committed in absorbing newer paradigms and using them to develop excellent human resource, innovative technologies and their dissemination so as to serve the livestock and fishery farming community of the state and the country. Various extension educational activities are undertaken by the university at various levels, viz., Extension Education, Extension Research, Extension Work and Extension Service. Collaborative activities are being planned and implemented in association with various stakeholders like Farmers, Farmers’ organizations, Department of Animal Husbandry and Veterinary Services, Karnataka Milk Federation, etc. Besides conducting routine extension activities like trainings, demonstrations, animal health camps, field trips, field tours, campaigns, livestock shows etc., KVAFSU has come out with some innovative approaches in extension education. Which are presented in this book chapter. Extension activities are undertaken mainly under two categories, i.e. university / college activities and collaborative / sponsored activities.
I. Innovative Extension Approaches Under University / College Activities Organization of Radio Series for Farming Community Radio remains an effective medium for disseminating veterinary knowledge, especially in rural areas. KVAFSU collaborates with radio stations to
• Broadcast expert talks on Veterinary and Animal Husbandry topics. More than 150 expert talks from Veterinary college Hassan, entitled as Gokulavani series, Kukkutavani series, Hainnu Honnu series I, II, II are broadcasted through AIR Hassan. Presently, Hainnu Honnu series IV is being executed with another 50 series of expert talks and skits as well.

Introduction 
Rural entrepreneurship is not only important as a means of generating employment opportunities in the rural areas with low capital cost and raising the real income of the people, but also its contribution to the development of agriculture and urban industries Building capacity of Rural Agri-prenuers are a promising solution for unemployment (Renuka, 2020), migration, economic disparity, reduce poverty, development of rural areas and backward regions. Most of the rural populace is associated with agriculture and allied activities as pedigree occupation. However, to be commercially viable, these units need to sharpen their skill sets to thrive as a successful venture. India is home to about 700 tribal groups with a population of 104 million, as per 2011 census. This indigenous people constitute the second largest tribal population in the world after Africa. Tribal population of Jammu & Kashmir is among the nascent Tribal Groups joining the main stream of planned development, to which they have brought a distinct and colourful cultural variety. Their economy is closely linked with the forests and they are living a substandard life because of their primitive mode of livelihood. Majority of them are placed below the poverty line, possessing meagre assets and are exclusively dependent on wages, forest produce and farming, that too in a traditional way which leads to non remunerative returns. The peculiar aspect of tribals of our state is their scattered population who inhabit the difficult and remote geographic terrains which poses a severe threat to their speedy development. In J&K state the following communities have been declared as scheduled tribes 1. Balti, 2. Beda, 3. Bot, Bota, 4. Brokpa, Drokpa, Dard, Shin, 5. Changpa, Garran, 6. Mon, 8. Purigpa, 9. Gujjar, 10. Bakerwal, 11. Gaddi and 12. Sippi.

Introduction
In the paradigm of development, the Government of India generated a Central Sector Scheme for the people associated with agriculture – a sector contributing to 18.2 per cent of the nation’s GDP, titled “Formation and Promotion of 10,000 Farmer Produce Organizations (FPOs)” with major focus on upheaval of farming community. With well-defined strategy and committed resources the Scheme is set-out to formulate 10,000 new FPOs in the country with budgetary provision of Rs 6865 crore. At the core of formation of each FPO, that are to be developed in produce clusters, wherein agricultural and horticultural produces are grown / cultivated for leveraging economies of scale and improving market access for members. “One District-One Product” cluster to promote specialization and better processing, marketing, branding & export. Under this Central Sector Scheme with funding from Government of India, Formation & Promotion of FPOs are to be done through the Implementing Agencies (IAs). Presently 09 Implementing Agencies (IAs) have been finalized for formation and promotion of FPOs viz. Small Farmers Agri-Business Consortium (SFAC), National Cooperative Development Corporation (NCDC), National Bank for Agriculture and Rural Development (NABARD), National Agricultural Cooperative Marketing Federation of India (NAFED), North Eastern Regional Agricultural Marketing Corporation Limited (NERAMAC), Tamil Nadu-Small Farmers Agri-Business Consortium (TN-SFAC), Small Farmers Agri-Business Consortium Haryana (SFACH), Watershed Development Department (WDD)- Karnataka, and Foundation for Development of Rural Value Chains (FDRVC)- Ministry of Rural Development (MoRD). The Implementing Agencies (IAs) engage Cluster Based Business Organizations (CBBOs) to aggregate, register & provide professional handholding support to each FPO for a period of 5 years. CBBOs have been empanelled & engaged by IAs. CBBOs operate as an end-to-end knowledge for all issues related to FPO promotion. During 2020-21, a total of 2200 FPO produce clusters were allocated for formation of FPOs, which also include specialized FPO produce clusters such as 100 FPOs for Organic, 100 FPOs for Oil seeds, etc. Of these, 369 FPOs are targeted for 115 aspirational districts in the country. Additionally, NAFED would form the specialized FPOs which should necessarily be forwardly linked to the market, agri-value chain, etc. NAFED will provide market and value chain linkages to the FPOs formed by other Implementing Agencies. NAFED has formed & registered 05 Honey FPOs during current year in Uttar Pradesh, Madhya Pradesh, Rajasthan, Bihar and West Bengal. FPOs are earmarked to provide financial assistance upto Rs 18.00 lakh per FPO for a period of 03 years. In addition to this, provision has been made for matching equity grant upto Rs. 2,000 per farmer member of FPO with a limit of Rs. 15.00 lakh per FPO and a credit guarantee facility upto Rs. 2 crore of project loan per FPO from eligible lending institution to ensure institutional credit accessibility to FPOs.

Introduction 
The agriculture scenario has evolved considerably over the years. In the present context, consumers need diverse, safe and nutritious food which calls for a major reorganisation of the agricultural value chains to support transformation from the traditional production-oriented supply chains to demand-based approaches. Trade liberalization has further intensified competition by exposing farmers to both domestic and international markets, compelling them to meet elevated standards in terms of product quality and pricing. Therefore, the primary focus should be on enhancing technical expertise, managerial capabilities and access to timely information to enable smallholder farmers not only to strengthen their livelihoods but also enhance their marketing skills amid the fast-evolving global economic landscape. Access to true information is equally essential for addressing growing challenges related to natural resource degradation and climate change. Extension in Indian context, play a vital role in bridging the knowledge gap between research institutions and farmers by providing a range of advisory amenities and facilitate expertise application, transmission and management in the farmer’s fields. Perhaps, agricultural extension is the only service at the ground-level that can provide essential knowledge, guidance, information as well as assistance to the farmers and the stakeholders. There has been extensive range of transformation and inventiveness in agricultural extension services in India; however, the exposure and access to information which were disseminated to marginal and underprivileged farmers are uneven and patchy. Likewise, in real situation a huge gap existed between the technology developed/released and the technology disseminated/adopted. A study by NSSO (National Sample Survey Organisation), 2014, highlighted that the almost 59 per cent of the farm families refrained from any assistance from either government or private extension services. In the country, 40.6 per cent households received extension assistance while, only 11 per cent of the services came from physical government machineries. At present hardly onethird of the technology developed at the research organizations has reached the farming community and the statistics of adoption/application of such technology at field level is even less than that. Practical application of many of our recommended agricultural technologies in the field is very much difficult either because of the complex nature of the technology or inputs so prescribed are not readily available in nearby areas. Moreover, most of the extension machineries tend to work in isolation from each other. The production-oriented strategy which was the sole focus of earlier extension services, needs to be expanded to market-led strategy to deal with the novel